KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Operating Income (2017 - 2025)

Historic Operating Income for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $167.0 million.

  • Elanco Animal Health's Operating Income rose 14925.37% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 10529.27%. This contributed to the annual value of -$1.5 billion for FY2024, which is 5153.55% up from last year.
  • Latest data reveals that Elanco Animal Health reported Operating Income of $167.0 million as of Q3 2025, which was up 14925.37% from $221.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Operating Income high stood at $249.0 million for Q1 2025, and its period low was -$1.6 billion during Q3 2023.
  • Its 5-year average for Operating Income is -$457.3 million, with a median of -$516.0 million in 2022.
  • Its Operating Income has fluctuated over the past 5 years, first crashed by 20697.67% in 2023, then soared by 14950.3% in 2025.
  • Quarter analysis of 5 years shows Elanco Animal Health's Operating Income stood at -$635.0 million in 2021, then grew by 15.43% to -$537.0 million in 2022, then decreased by 19.74% to -$643.0 million in 2023, then rose by 14.15% to -$552.0 million in 2024, then surged by 130.25% to $167.0 million in 2025.
  • Its Operating Income stands at $167.0 million for Q3 2025, versus $221.0 million for Q2 2025 and $249.0 million for Q1 2025.